Medicare Enrolled
Dr. Cyril Tawa, M.D.
Cardiovascular Disease · Cypress, TX
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tawa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tawa? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tawa
Dr. Cyril Tawa is a cardiovascular disease in Cypress, TX, with 19 years in practice. Based on federal Medicare data, Dr. Tawa performed 6,868 Medicare services across 4,044 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tawa received a total of $8,819 from 40 pharmaceutical and/or device companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tawa is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 9% volume in TX$ $8,819 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,868
Medicare services
Top 9% in TX for cardiovascular disease
4,044
Unique beneficiaries
$150
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~361 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,808 | $91 | $200 |
| Electrocardiogram (EKG), 12-lead | 1,018 | $11 | $95 |
| Regadenoson injection (Lexiscan) for heart stress test | 876 | $44 | $300 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 547 | $29 | $195 |
| Echocardiogram, transthoracic | 354 | $138 | $754 |
| Infusion, normal saline solution, 250 cc | 296 | $1 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 252 | $57 | $300 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 214 | $701 | $1,362 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 213 | $1,952 | $4,500 |
| Hospital follow-up visit, moderate complexity | 159 | $65 | $300 |
| Nuclear medicine study of heart muscle blood flow by pet | 144 | $147 | $500 |
| Ultrasound of both sides of head and neck blood flow | 115 | $143 | $600 |
| Prothrombin time test (blood clotting) | 89 | $4 | $15 |
| New patient office visit (45-59 min) | 85 | $111 | $262 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 79 | $7 | $25 |
| Remote pacemaker monitoring, 90 days | 76 | $23 | $50 |
| Evaluation of cardiac rhythm monitor system | 73 | $37 | $75 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 61 | $208 | $800 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 60 | $44 | $65 |
| Office visit, established patient (20-29 min) | 55 | $64 | $155 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $18 | $82 |
| Initial hospital admission, moderate complexity | 43 | $105 | $215 |
| Office visit, established patient, complex (40-54 min) | 39 | $137 | $200 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $10 | $20 |
| Cardiac catheterization | 24 | $188 | $1,500 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 20 | $66 | $112 |
| Initial hospital admission, high complexity | 19 | $141 | $552 |
| Transitional care management services for problem of high complexity | 18 | $225 | $500 |
| Insertion of heart rhythm monitor under skin | 17 | $3,557 | $10,000 |
| Coronary stent placement | 13 | $479 | $3,200 |
| Transitional care management services for problem of at least moderate complexity | 12 | $166 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.1% high complexity
23.3% medium
63.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,819
Total received (2018-2024)
Avg $1,260/year across 7 years
Top 35% in TX for cardiovascular disease
40
Companies
416
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,799 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$954
2023$1,339
2022$1,476
2021$1,303
2020$781
2019$1,376
2018$1,590
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,404
Amgen Inc.
$1,049
Janssen Pharmaceuticals, Inc
$894
Boston Scientific Corporation
$745
E.R. Squibb & Sons, L.L.C.
$530
Medtronic, Inc.
$384
Astellas Pharma US Inc
$351
Boehringer Ingelheim Pharmaceuticals, Inc.
$328
PFIZER INC.
$322
Medtronic Vascular, Inc.
$301
Novartis Pharmaceuticals Corporation
$294
Amarin Pharma Inc.
$275
AstraZeneca Pharmaceuticals LP
$217
Merck Sharp & Dohme LLC
$193
Gilead Sciences, Inc.
$156
SANOFI-AVENTIS U.S. LLC
$143
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$131
BOSTON SCIENTIFIC CORPORATION
$105
Lundbeck LLC
$104
NOVARTIS PHARMACEUTICALS CORPORATION
$95
Edwards Lifesciences Corporation
$91
Kowa Pharmaceuticals America, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$82
Esperion Therapeutics, Inc.
$70
Kiniksa Pharmaceuticals, Ltd.
$50
CARDIVA MEDICAL, INC.
$48
ARBOR PHARMACEUTICALS, INC.
$48
Impulse Dynamics (USA) Inc.
$43
Azurity Pharmaceuticals, Inc.
$42
AGEPHA Pharma FZ LLC
$35
Actelion Pharmaceuticals US, Inc.
$34
Recor Medical Inc
$25
Preventice Services, LLC
$25
Itamar Medical Inc
$25
BIOTRONIK INC.
$20
CVRx, Inc.
$18
Aziyo Biologics, Inc.
$15
AtriCure, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
SCPHARMACEUTICALS INC.
$14
Top 3 companies account for 37.9% of total payments
Associated products mentioned in payments ›
AZURE XT DR MRI SURESCAN · Arcalyst · Assurity Pacemaker · Azure · BG Mini Plus · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · CareLink · Claria MRI · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · ECM · EDARBI · EDARBYCLOR · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · JARDIANCE · LEQVIO · LEXISCAN · LINQ II · LIVALO · LODOCO · LUX DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · Livalo · MITRACLIP · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · NORTHERA · OPSUMIT MACITENTAN · Optimizer · Optimizer Smart System · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QUADRA ASSURA · QUARTET · Quartet CRT Lead · RESONATE · REVEAL LINQ · Repatha · Resolute · Reveal LINQ · SAPIEN 3 Ultra RESILIA · UPTRAVI · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $128 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
199
Per 100K population
4.2
County median income
$73,104
Nearest hospital
LONE STAR BEHAVIORAL HEALTH CYPRESS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tawa is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 9% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tawa experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tawa performed 1,808 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tawa receive payments from pharmaceutical companies?
Yes. Dr. Tawa received a total of $8,819 from 40 companies across 416 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tawa's costs compare to other cardiovascular diseases in Cypress?
Dr. Tawa's average Medicare payment per service is $150. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tawa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Cypress
Browse cardiovascular diseases in Cypress ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology